Kingsview Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-400
Closed -$1K – 758
2020
Q3
$1K Buy
+400
New +$61.9K ﹤0.01% 631
2019
Q1
– Sell
-200
Closed -$2K – 507
2018
Q4
$2K Buy
+200
New +$22.3K ﹤0.01% 360

Other funds holding LLY

Kingsview Wealth Management's LLY Position: Q2 2026 in Review

Kingsview Wealth Management increased its Eli Lilly (LLY) stake by 8.8% in Q2 2026, buying an estimated $6.76M and bringing the position to 82,083 shares worth $98.5M. The position accounts for 1.19% of the portfolio, ranked #13.

Kingsview Wealth Management first reported a position in LLY in Q3 2018 and has held it in 32 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kingsview Wealth Management held 82,083 shares of Eli Lilly worth $98.5M as of Q2 2026.
  • Kingsview Wealth Management bought 6,612 Eli Lilly shares in Q2 2026, an estimated $6.76M.
  • Eli Lilly made up 1.19% of Kingsview Wealth Management's portfolio in Q2 2026, its #13 holding.
  • Kingsview Wealth Management first reported a position in Eli Lilly in Q3 2018 and has held it in 32 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.